A carregar...
Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
Improving treatment outcomes in multidrug‐resistant tuberculosis (MDR‐TB) is partly hampered by inadequate effective antitubercular agents. Development of bedaquiline and delamanid has potentially changed the treatment landscape for MDR‐TB. This review provides an update on the progress of these nov...
Na minha lista:
| Publicado no: | Drug Dev Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590425/ https://ncbi.nlm.nih.gov/pubmed/30548290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21498 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|